Bo Chen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Network Analysis

Binding Protein

Top Venues

BioMed research international

OncoTargets and therapy

Cell death and differentiation

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Yuanyuan Yan, Miao He, Lin Zhao, Huizhe Wu, Yanyun Zhao, Li Han, Binbin Wei, Dong-Man Ye, Xuemei Lv, Yan Wang, Weifan Yao, Haishan Zhao, Bo Chen, Zining Jin, Jian Wen, Yan Zhu, Tao Yu, Feng Jin, Min-Jie Wei
A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPR ER axis. Cell death and differentiation 29 (9) (2022)
Ming Wu, Yujie Zhao, Nanxi Peng, Zuo Tao, Bo Chen
Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis. Investigational new drugs 39 (3) (2021)
Ye Liu, Li-Li Li, Lei Xu, Dong-Dong Feng, Yu Cao, Xiao-Yun Mao, Jin Zheng, Feng Jin, Bo Chen
Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. BioMed research international 2020 (2020)
Zuo Tao, Huandan Suo, Lei Zhang, Zining Jin, Zhen Wang, Danyu Wang, Ming Wu, Nanxi Peng, Yujie Zhao, Bo Chen
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer. OncoTargets and therapy 13 (2020)
Huan-Dan Suo, Zuo Tao, Lei Zhang, Zi-Ning Jin, Xiao-Ying Li, Wei Ma, Zhen Wang, Yue Qiu, Feng Jin, Bo Chen, Yu Cao
Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer. BioMed research international 2020 (2020)